The IRE Resource Center is a major research library containing more than 23,250 investigative stories — both print and broadcast. These stories are searchable online or by contacting the Resource Center directly (573-882-3364 or email@example.com) where a researcher can help you pinpoint what you need. Browse or search the tipsheet section of our library below. Stories are not available for download but can be easily ordered by contacting the Resource Center:
The IRE Resource Center is a major research library containing more than 23,250 investigative stories — both print and broadcast.
These stories are searchable online or by contacting the Resource Center directly (573-882-3364 or firstname.lastname@example.org) where a researcher can help you pinpoint what you need.
Browse or search the tipsheet section of our library below. Stories are not available for download but can be easily ordered by contacting the Resource Center:
Search results for "bone cancer" ...
This series detailed how high levels of radium 226/228, known human carcinogens linked to bone and nasal cancers, contaminated public drinking water wells that provided water to thousands of people in Northwest Florida between 1996-2000. The public utility responsible for water safety resisted state efforts to clean the radioactive material and inform the public, because it cost too much money. The Utilities Authority conducted tapwater samples that measured high concentrations of radium coming out of fountains at an elementary school, regional airport, government offices, and the tourist welcome center, but the results of these samples were never made public.
Tags: radium; human carcinogens; bone cancer; nasal cancer; contaminated drinking water wells; radioactive material; Escambia County Utilities Authority; drinking water; Agrico Chemical Co. Superfund hazardous waste; U.S. Florida Department of Environmental protection; radium-tainted water; Escambia County Health Department; Pensacola Regional Airport; Santa Rosa Island Authority; Cordova Park Elementary School; Office of Ground Water and Drinking Water; American Agricultural Chemical Co.; U.S. Geological Survey; maximum contamination level; MCL; Northwest Florida Management District; water cleanup; Environmental Protection Agency; "limited action" cleanup DuPont; ConocoPhillips; Conoco Inc.; The Williams Co.; Freeport-McMoRan Inc.
Uninformed Consent: What patients at "The Hutch' weren't told about the experiments in which they died.
"PATIENTS DIED PREMATURELY in two failed clinical trials at Seattle's Fred Hutchinson Cancer Research Center-- experiments in which the Center and its doctors had a financial interest. The patients and their families were never told about those connections, nor were they fully and properly informed about the risks of the experiments ... The patients in these trials were ill with cancers that, left untreated, would almost certainly have killed them. But many stood a good chance of survival or at least prolonged life with traditional care. Instead, many actually died from the experiments --sooner than they would have with no treatment at all."
Tags: conflict of interest; T- cells; bone marrow transplants; clinical trial; disclosure; biotechnology; breast cancer; IRB; Institutional Review Board; chemotherapy; stem-cell transplant; Pentoxifylline; PTX; nonprofit; hospital
This report examines "speculation among breast cancer activists that release of results of autologous bone marrow transplant therapy were being delayed unnecessarily."
Time Magazine tells the story of Christy DeMeures, a young California mother with breast cancer, and Health Net, a large, aggressive HMO that resisted her pleas for the bone marrow transplant that doctors felt represented the only chance of saving her life. DeMeures encountered a pattern of manipulation by the HMO, whereby doctors who initially agreed she should seek advanced treatment suddenly changed their minds and demeanor. DeMeures eventually died, leaving her family and at least one of her doctors wondering if the outcome would have been different if she had gotten the treatment she asked for.
San Francisco Daily Journal series details the growing litigation over a new and controversial treatment to fight breast and other cancers: high-dose chemotherapy with autologous bone marrow transplants; insurers have labeled the treatment experimental, and are refusing to cover it under most policies; desperate patients are going to court to force insurers to pay for the treatment and, more often than not, they are winning, Dec. 21 - 22, 1992.